Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Martina de Zwaan |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors / James L. Roerig en Journal of Clinical Psychopharmacology, Año 2005 - Vol. 25 - No. 5 (Octubre)
[artículo]
Título : A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors Tipo de documento: texto impreso Autores: James L. Roerig, Autor ; James E. Mitchell, Autor ; Martina de Zwaan, Autor Fecha de publicación: 2023 Artículo en la página: pp. 413-418 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiazepinas, Ingesta de energía, Comportamiento alimentario, Olanzapina, Risperidona. Resumen: To thoroughly investigate the phenomenon of atypical antipsychotic associated weight gain, a feeding laboratory paradigm was developed. This study is a randomized, double-blind, parallel group trial comparing the tolerability and effects of a two-week exposure to olanzapine, risperidone or placebo on weight, resting energy expenditure (REE), and eating behaviors in 48 healthy human subjects. Link: ./index.php?lvl=notice_display&id=30885
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 5 (Octubre) . - pp. 413-418[artículo] A comparison of the effects of olanzapine and risperidone versus placebo on eating behaviors [texto impreso] / James L. Roerig, Autor ; James E. Mitchell, Autor ; Martina de Zwaan, Autor . - 2023 . - pp. 413-418.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 5 (Octubre) . - pp. 413-418
Palabras clave: Antipsicóticos, Benzodiazepinas, Ingesta de energía, Comportamiento alimentario, Olanzapina, Risperidona. Resumen: To thoroughly investigate the phenomenon of atypical antipsychotic associated weight gain, a feeding laboratory paradigm was developed. This study is a randomized, double-blind, parallel group trial comparing the tolerability and effects of a two-week exposure to olanzapine, risperidone or placebo on weight, resting energy expenditure (REE), and eating behaviors in 48 healthy human subjects. Link: ./index.php?lvl=notice_display&id=30885